Patent Assignment
Reel/Frame 066597/0394
Assignment of Assignor's Interest
Recorded: 2024-02-14
Pages: 24
Assignor
ID BIOMEDICAL CORPORATION OF QUEBEC
Executed: 2023-11-30
Assignee
GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED
GSK MEDICINES RESEARCH CENTRE, GUNNELS WOOD ROAD, STEVENAGE, SG1 2NY, UNITED KINGDOM
Covered Property
(1)
Preparation of P2X3 Antagonist
Application:
18/683,520 →
Publication:
US 2024/0351992
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 14, 2024
From: VILLENEUVE, KARINE; KRONENTHAL, DAVID
To: BELLUS HEALTH COUGH INC.
Reel/Frame 066458/0587 →
Merger
Feb 14, 2024
From: BELLUS HEALTH COUGH INC.
To: BELLUS HEALTH INC.
Reel/Frame 066596/0782 →
Assignment of Assignor's Interest
Feb 14, 2024
From: BELLUS HEALTH INC.
To: 14245563 CANADA INC.
Reel/Frame 066596/0934 →
Assignment of Assignor's Interest
Feb 14, 2024
From: 14245563 CANADA INC.
To: ID BIOMEDICAL CORPORATION OF QUEBEC
Reel/Frame 066597/0347 →
Change of Address
Apr 16, 2025
From: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED
Reel/Frame 071351/0192 →